SAN CARLOS, Calif., Jan. 21, 2021 /PRNewswire/ — Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the proprietary CENTAURI™ System will be featured in a recorded case presentation on Sunday January 31st during the upcoming AF Symposium. Ante Anić, EP Lab Director at University Hospital […]
Rhythm
Argos Cardiac Output Monitor Earns CE Mark Approval
VALHALLA, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) — Retia Medical, a leading provider of minimally-invasive hemodynamic monitoring technology today announced it received CE (Conformitè Europëenne) Mark approval for its Argos Cardiac Output Monitor. Retia’s CEO Marc Zemel stated, “Obtaining the CE mark for the Argos Cardiac Output Monitor is a […]
Cardialen Awarded $2.8 Million Federal Grant to Advance Therapy Designed to Treat Dangerous Heart Rhythms
National Institutes of Health grant will support Cardialen’s development of its implantable, low-energy therapy designed to treat atrial fibrillation, a cardiac arrhythmia associated with debilitating shortness of breath, fatigue, pain, and an increased risk of stroke. MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., has been awarded a $2.8 million National Institutes of Health (NIH) […]
2-French Electrophysiology Microcatheter Launches in Europe, Enabling Deeper Coronary Sinus Mapping
TORONTO, Jan. 19, 2021 /PRNewswire/ — Baylis Medical announced today the launch and first clinical case in Europe of the JLL 2-French electrophysiology microcatheter, performed by Dr. Thomas Deneke at Heart Center, Bad Neustadt, Germany. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the […]
InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation
Ongoing Trial to Evaluate Optimal Dose Selected from Dose-Ranging Stage of the INSTANT Study for Rapid Conversion of Atrial Fibrillation to Normal Sinus Rhythm SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced dosing […]
Home-based Heart Monitoring Now Available to All Canadians Through Icentia
Canadian company drives at-home cardiac monitoring nationwide during pandemic QUEBEC CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) — Icentia Inc., a leading Canadian technology company—specialised in cardiac ambulatory monitoring—will be providing a new home-based service nationwide that will enable patients with heart rhythm disorders to have access to an ambulatory cardiac […]
BioSig PURE EP System Featured in the Editorial of EP Lab Digest
Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) — Leading industry publication calls attention to ongoing challenges in the electrophysiology lab PURE EP System is highlighted as a novel technological solution BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed […]
VivaLNK Provides Cardiac Patch for Sleep Bruxism Study
Wearable ECG monitor used in study on Emotion Dysregulation and Sleep Time Masticatory Muscle Activity CAMPBELL, Calif., Jan. 13, 2021 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, announces an agreement to supply its wearable ECG monitors to Stanford University for research on sleep bruxism. Titled “Emotion Dysregulation and Sleep-Time Masticatory Muscle Activity […]
FineHeart Successfully Tests the Implantable, Wireless Transcutaneous Energy Transfer (TET) System for Powering Its ICOMS Heart Pump
A major step and a critical milestone achieved prior to First In Human clinical trials FineHeart’s TET is a system with no percutaneous driveline that transfers energy through the skin to charge the ICOMS pump battery TET is rapidly implantable (less than 15 mins) and will give patients autonomy The […]
Anura™: World’s first app allowing for contactless blood pressure measurement, without the need for cuffs or other wearables
The Affective AI-based app, contactlessly records and measures blood pressure and over ten other physiological and psychological indexes. TORONTO, Jan. 12, 2021 /PRNewswire/ — Toronto-based tech firm, NuraLogix, will be showcasing the groundbreaking app Anura™ at CES 2021. Originally debuted at CES Asia 2019, Anura™ is an Affective AI based app that allows contactless health […]



